Back
Fidelity Disruptive Finance ETF Vs. Krystal Biotech, Inc. Sector Stock Comparison
Buy
76
FDFF
Fidelity Disruptive Finance ETF
Last Price:
$35.89
Seasonality Move:
4.29%
Buy
75
KRYS
Krystal Biotech, Inc.
Last Price:
$240.89
Seasonality Move:
5.72%
Buy
76
Fidelity Disruptive Finance ETF (FDFF)
is a Buy
Is Fidelity Disruptive Finance ETF a Buy, Sell or Hold?
-
The current Fidelity Disruptive Finance ETF [FDFF] share price is $35.86. The Score for FDFF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
-
FDFF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
75
Krystal Biotech, Inc. (KRYS)
is a Buy
Is Krystal Biotech, Inc. a Buy, Sell or Hold?
-
The current Krystal Biotech, Inc. [KRYS] share price is $240.80. The Score for KRYS is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
KRYS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDFF Stock Price Chart
What is Fidelity Disruptive Finance ETF's stock price today?
-
The Fidelity Disruptive Finance ETF share price today is $35.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDFF is experiencing slight buying pressure.
KRYS Stock Price Chart
What is Krystal Biotech, Inc.'s stock price today?
-
The Krystal Biotech, Inc. share price today is $240.80Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KRYS is experiencing slight buying pressure.
FDFF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 59.75 | Buy |
| Chaikin Money Flow: | 113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.73 - 35.57) | Buy |
| Bollinger Bands (100): | (34.78 - 37.46) | Sell |
KRYS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.84 | Buy |
| Relative Strength Index (14 RSI): | 68.35 | Buy |
| Chaikin Money Flow: | 226476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (210.18 - 238.06) | Buy |
| Bollinger Bands (100): | (150.15 - 213.59) | Buy |
FDFF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.66 | Buy |
| 20-day SMA: | 34.97 | Buy |
| 50-day SMA: | 34.98 | Buy |
| 200-day SMA: | 36.21 | Sell |
| 8-day EMA: | 35.54 | Buy |
| 20-day EMA: | 35.18 | Buy |
| 50-day EMA: | 35.27 | Buy |
| 200-day EMA: | 35.89 | Sell |
KRYS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 240.33 | Buy |
| 20-day SMA: | 228.78 | Buy |
| 50-day SMA: | 208.63 | Buy |
| 200-day SMA: | 167.73 | Buy |
| 8-day EMA: | 237.28 | Buy |
| 20-day EMA: | 229.15 | Buy |
| 50-day EMA: | 210.93 | Buy |
| 200-day EMA: | 178.26 | Buy |
Fidelity Disruptive Finance ETF Earnings Growth & FDFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Krystal Biotech, Inc. Earnings Growth & KRYS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.37 per share, and an increase next year of $1.76 per share.
Fidelity Disruptive Finance ETF Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Krystal Biotech, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||